{"actionType":"POSITIVE MODULATOR","mechanismOfAction":"GABA-A receptor; anion channel positive modulator","chemblIds":["CHEMBL2068724","CHEMBL1201293"],"targetName":"GABA-A receptor; anion channel","targetType":"protein complex group","targets":["ENSG00000022355","ENSG00000145864","ENSG00000113327","ENSG00000166206","ENSG00000109158","ENSG00000182256","ENSG00000268089","ENSG00000011677","ENSG00000094755","ENSG00000187730","ENSG00000163285","ENSG00000163288","ENSG00000102287","ENSG00000151834","ENSG00000186297","ENSG00000145863"],"references":[{"source":"ISBN","ids":["9780702034718  PP. 596"],"urls":["http://www.isbnsearch.org/isbn/9780702034718"]},{"source":"Wikipedia","ids":["Acamprosate","Acamprosate"],"urls":["http://en.wikipedia.org/wiki/Acamprosate","http://en.wikipedia.org/wiki/Acamprosate"]},{"source":"FDA","ids":["label/2012/021431s015lbl.pdf","label/2012/021431s015lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf","http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021431s015lbl.pdf"]},{"source":"PubMed","ids":["22346357","15963001","18540918","22346357"],"urls":["http://europepmc.org/abstract/MED/22346357","http://europepmc.org/abstract/MED/15963001","http://europepmc.org/abstract/MED/18540918","http://europepmc.org/abstract/MED/22346357"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Beta-nerve growth factor inhibitor","chemblIds":["CHEMBL2109527"],"targetName":"Beta-nerve growth factor","targetType":"single protein","targets":["ENSG00000134259"],"references":[{"source":"PubMed","ids":["27995962"],"urls":["http://europepmc.org/abstract/MED/27995962"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase JAK3 inhibitor","chemblIds":["CHEMBL3545159"],"targetName":"Tyrosine-protein kinase JAK3","targetType":"single protein","targets":["ENSG00000105639"],"references":[{"source":"Other","ids":["http://www.rigel.com/index.php/pipeline/","http://www.rigel.com/index.php/pipeline/"],"urls":["http://www.rigel.com/index.php/pipeline/","http://www.rigel.com/index.php/pipeline/"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Mu opioid receptor antagonist","chemblIds":["CHEMBL2364619"],"targetName":"Mu opioid receptor","targetType":"single protein","targets":["ENSG00000112038"],"references":[{"source":"Other","ids":["http://investor.alkermes.com/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=1227200"],"urls":["http://investor.alkermes.com/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=1227200"]},{"source":"PubMed","ids":["22056608"],"urls":["http://europepmc.org/abstract/MED/22056608"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Serotonin 2a (5-HT2a) receptor antagonist","chemblIds":["CHEMBL1108"],"targetName":"Serotonin 2a (5-HT2a) receptor","targetType":"single protein","targets":["ENSG00000102468"],"references":[{"source":"ISBN","ids":["0443-059748"],"urls":["http://www.isbnsearch.org/isbn/0443059748"]},{"source":"Wikipedia","ids":["Antipsychotics","Droperidol","Droperidol"],"urls":["http://en.wikipedia.org/wiki/Antipsychotics","http://en.wikipedia.org/wiki/Droperidol","http://en.wikipedia.org/wiki/Droperidol"]},{"source":"PubMed","ids":["20832967","20832967"],"urls":["http://europepmc.org/abstract/MED/20832967","http://europepmc.org/abstract/MED/20832967"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Cyclooxygenase inhibitor","chemblIds":["CHEMBL1562610","CHEMBL509"],"targetName":"Cyclooxygenase","targetType":"protein family","targets":["ENSG00000073756","ENSG00000095303"],"references":[{"source":"PubMed","ids":["3020588","3020588"],"urls":["http://europepmc.org/abstract/MED/3020588","http://europepmc.org/abstract/MED/3020588"]},{"source":"DailyMed","ids":["setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d","setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=96f19af4-de8f-4fd7-90d8-55fe6ebdd81d"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H1 receptor antagonist","chemblIds":["CHEMBL17157"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"PubMed","ids":["22436","27203","6120713","6144348","9733666"],"urls":["http://europepmc.org/abstract/MED/22436","http://europepmc.org/abstract/MED/27203","http://europepmc.org/abstract/MED/6120713","http://europepmc.org/abstract/MED/6144348","http://europepmc.org/abstract/MED/9733666"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Beta-1 adrenergic receptor antagonist","chemblIds":["CHEMBL1700","CHEMBL471"],"targetName":"Beta-1 adrenergic receptor","targetType":"single protein","targets":["ENSG00000043591"],"references":[{"source":"Wikipedia","ids":["Sotalol","Sotalol","Sotalol"],"urls":["http://en.wikipedia.org/wiki/Sotalol","http://en.wikipedia.org/wiki/Sotalol","http://en.wikipedia.org/wiki/Sotalol"]},{"source":"DailyMed","ids":["setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c4caf469-f684-4f6d-98e8-b6a2fff1de98"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Acetylcholinesterase inhibitor","chemblIds":["CHEMBL1201341"],"targetName":"Acetylcholinesterase","targetType":"single protein","targets":["ENSG00000087085"],"references":[{"source":"FDA","ids":["label/2006/011963s034lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2006/011963s034lbl.pdf"]}]}
{"actionType":"CROSS-LINKING AGENT","mechanismOfAction":"DNA cross-linking agent","chemblIds":["CHEMBL3137322"],"references":[{"source":"PubMed","ids":["7387628"],"urls":["http://europepmc.org/abstract/MED/7387628"]},{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=39215"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=39215"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Adrenergic receptor alpha-1 agonist","chemblIds":["CHEMBL1723","CHEMBL709"],"targetName":"Adrenergic receptor alpha-1","targetType":"protein family","targets":["ENSG00000120907","ENSG00000171873","ENSG00000170214"],"references":[{"source":"DailyMed","ids":["setid=f075a897-7bef-4799-b7e2-7e051c461443#nlm34090-1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f075a897-7bef-4799-b7e2-7e051c461443#nlm34090-1"]}]}
{"actionType":"OTHER","mechanismOfAction":"Tenascin other","chemblIds":["CHEMBL2109583"],"targetName":"Tenascin","targetType":"single protein","targets":["ENSG00000041982"],"references":[{"source":"PubMed","ids":["18927291"],"urls":["http://europepmc.org/abstract/MED/18927291"]}]}
{"mechanismOfAction":"Diagnostic agent","chemblIds":["CHEMBL1201458"],"references":[{"source":"DailyMed","ids":["setid=511d1f64-5cb9-4baa-a123-96205467e59a"],"urls":["https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=511d1f64-5cb9-4baa-a123-96205467e59a"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL1983350"],"references":[{"source":"PubMed","ids":["24001087","25792327"],"urls":["http://europepmc.org/abstract/MED/24001087","http://europepmc.org/abstract/MED/25792327"]},{"source":"FDA","ids":["label/2018/206709s000,207223s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/206709s000,207223s000lbl.pdf"]},{"source":"Other","ids":["https://www.ema.europa.eu/documents/product-information/diacomit-epar-product-information_en.pdf"],"urls":["https://www.ema.europa.eu/documents/product-information/diacomit-epar-product-information_en.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase SRC inhibitor","chemblIds":["CHEMBL24828"],"targetName":"Tyrosine-protein kinase SRC","targetType":"single protein","targets":["ENSG00000197122"],"references":[{"source":"DailyMed","ids":["setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4dc7f0af-77fb-4eec-46b9-dd1c2dcb4525#section-13"]}]}
{"actionType":"BINDING AGENT","mechanismOfAction":"Lewis Y antigen binding agent","chemblIds":["CHEMBL2109503"],"references":[{"source":"PubMed","ids":["17059365"],"urls":["http://europepmc.org/abstract/MED/17059365"]},{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=43018"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=43018"]}]}
{"actionType":"BLOCKER","mechanismOfAction":"Sodium channel alpha subunit blocker","chemblIds":["CHEMBL529437","CHEMBL370805"],"targetName":"Sodium channel alpha subunit","targetType":"protein family","targets":["ENSG00000144285","ENSG00000183873","ENSG00000007314","ENSG00000136546","ENSG00000136531","ENSG00000169432","ENSG00000153253","ENSG00000168356","ENSG00000196876","ENSG00000185313"],"references":[{"source":"FDA","ids":["label/2020/209575s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/209575s000lbl.pdf"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL2108938"],"references":[{"source":"PubMed","ids":["23207754","25904581","27356144","27859922","28062458","28402558","8072713"],"urls":["http://europepmc.org/abstract/MED/23207754","http://europepmc.org/abstract/MED/25904581","http://europepmc.org/abstract/MED/27356144","http://europepmc.org/abstract/MED/27859922","http://europepmc.org/abstract/MED/28062458","http://europepmc.org/abstract/MED/28402558","http://europepmc.org/abstract/MED/8072713"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"PI3-kinase class I inhibitor","chemblIds":["CHEMBL1236962"],"targetName":"PI3-kinase class I","targetType":"protein complex group","targets":["ENSG00000145675","ENSG00000051382","ENSG00000105851","ENSG00000121879","ENSG00000105647","ENSG00000171608","ENSG00000141506","ENSG00000117461"],"references":[{"source":"PubMed","ids":["15705718","24900173","15705718","24900173"],"urls":["http://europepmc.org/abstract/MED/15705718","http://europepmc.org/abstract/MED/24900173","http://europepmc.org/abstract/MED/15705718","http://europepmc.org/abstract/MED/24900173"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Beta-1 adrenergic receptor antagonist","chemblIds":["CHEMBL499"],"targetName":"Beta-1 adrenergic receptor","targetType":"single protein","targets":["ENSG00000043591"],"references":[{"source":"DailyMed","ids":["setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce","setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=00f62dd1-dad2-4892-8a5d-21e5e54509ce"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Stem cell growth factor receptor inhibitor","chemblIds":["CHEMBL2109325"],"targetName":"Stem cell growth factor receptor","targetType":"single protein","targets":["ENSG00000157404"],"references":[{"source":"Other","ids":["http://www.creativebiolabs.net/Anti-KIT-Therapeutic-Antibody-AMG-191-19640.htm"],"urls":["http://www.creativebiolabs.net/Anti-KIT-Therapeutic-Antibody-AMG-191-19640.htm"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Dihydropyrimidine dehydrogenase inhibitor","chemblIds":["CHEMBL355200"],"targetName":"Dihydropyrimidine dehydrogenase","targetType":"single protein","targets":["ENSG00000188641"],"references":[{"source":"PubMed","ids":["10037177","24183612"],"urls":["http://europepmc.org/abstract/MED/10037177","http://europepmc.org/abstract/MED/24183612"]}]}
{"actionType":"ACTIVATOR","mechanismOfAction":"Soluble guanylate cyclase activator","chemblIds":["CHEMBL730"],"targetName":"Soluble guanylate cyclase","targetType":"protein complex group","targets":["ENSG00000061918","ENSG00000123201","ENSG00000152402","ENSG00000164116"],"references":[{"source":"FDA","ids":["label/2016/021780s007lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/021780s007lbl.pdf"]},{"source":"Wikipedia","ids":["Nitric_oxide","Nitroglycerin","Nitrovasodilator","Soluble_guanylyl_cyclase"],"urls":["http://en.wikipedia.org/wiki/Nitric_oxide","http://en.wikipedia.org/wiki/Nitroglycerin","http://en.wikipedia.org/wiki/Nitrovasodilator","http://en.wikipedia.org/wiki/Soluble_guanylyl_cyclase"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Interleukin-1 receptor inhibitor","chemblIds":["CHEMBL2109607"],"targetName":"Interleukin-1 receptor","targetType":"single protein","targets":["ENSG00000115594"],"references":[{"source":"PMC","ids":["PMC5551010"],"urls":["http://europepmc.org/articles/PMC5551010"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA polymerase (alpha/delta/epsilon) inhibitor","chemblIds":["CHEMBL4297599"],"targetName":"DNA polymerase (alpha/delta/epsilon)","targetType":"protein family","targets":["ENSG00000101868","ENSG00000175482","ENSG00000077514","ENSG00000062822","ENSG00000106628","ENSG00000177084","ENSG00000014138","ENSG00000198056","ENSG00000146143","ENSG00000100479","ENSG00000148229"],"references":[{"source":"PubMed","ids":["31770437","31770437","31770437"],"urls":["http://europepmc.org/abstract/MED/31770437","http://europepmc.org/abstract/MED/31770437","http://europepmc.org/abstract/MED/31770437"]},{"source":"DailyMed","ids":["setid=1315f89d-f530-4dff-98e5-27d51617d4a1","setid=1315f89d-f530-4dff-98e5-27d51617d4a1","setid=1315f89d-f530-4dff-98e5-27d51617d4a1"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1315f89d-f530-4dff-98e5-27d51617d4a1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1315f89d-f530-4dff-98e5-27d51617d4a1","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1315f89d-f530-4dff-98e5-27d51617d4a1"]}]}
{"actionType":"CROSS-LINKING AGENT","mechanismOfAction":"DNA cross-linking agent","chemblIds":["CHEMBL460287"],"references":[{"source":"PubMed","ids":["32958106"],"urls":["https://pubmed.ncbi.nlm.nih.gov/32958106/"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","chemblIds":["CHEMBL4297865"],"targetName":"Epidermal growth factor receptor erbB1","targetType":"single protein","targets":["ENSG00000146648"],"references":[{"source":"ClinicalTrials","ids":["NCT02330367","NCT02330367","NCT02330367"],"urls":["https://www.clinicaltrials.gov/ct2/show/NCT02330367","https://www.clinicaltrials.gov/ct2/show/NCT02330367","https://www.clinicaltrials.gov/ct2/show/NCT02330367"]},{"source":"PubMed","ids":["27573423","29392403","32127939","27573423","29392403","32127939","27573423","29392403","32127939"],"urls":["http://europepmc.org/abstract/MED/27573423","http://europepmc.org/abstract/MED/29392403","http://europepmc.org/abstract/MED/32127939","http://europepmc.org/abstract/MED/27573423","http://europepmc.org/abstract/MED/29392403","http://europepmc.org/abstract/MED/32127939","http://europepmc.org/abstract/MED/27573423","http://europepmc.org/abstract/MED/29392403","http://europepmc.org/abstract/MED/32127939"]},{"source":"Other","ids":["https://mct.aacrjournals.org/content/15/11/2586.long","https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/","https://www.sciencedirect.com/science/article/pii/S2590098620300221","https://mct.aacrjournals.org/content/15/11/2586.long","https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/","https://www.sciencedirect.com/science/article/pii/S2590098620300221","https://mct.aacrjournals.org/content/15/11/2586.long","https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/","https://www.sciencedirect.com/science/article/pii/S2590098620300221"],"urls":["https://mct.aacrjournals.org/content/15/11/2586.long","https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/","https://www.sciencedirect.com/science/article/pii/S2590098620300221","https://mct.aacrjournals.org/content/15/11/2586.long","https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/","https://www.sciencedirect.com/science/article/pii/S2590098620300221","https://mct.aacrjournals.org/content/15/11/2586.long","https://sorrentotherapeutics.com/research/immuno-oncology/abivertinib/","https://www.sciencedirect.com/science/article/pii/S2590098620300221"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Glucocerebroside hydrolytic enzyme","chemblIds":["CHEMBL1201865"],"references":[{"source":"DailyMed","ids":["setid=ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ca02f7a4-ae4f-43c1-a06a-259fe4fcf9cf"]}]}
{"actionType":"DISRUPTING AGENT","mechanismOfAction":"Cell membrane disrupting agent","chemblIds":["CHEMBL1615933"],"references":[{"source":"PubMed","ids":["17383609","20053150"],"urls":["http://europepmc.org/abstract/MED/17383609","http://europepmc.org/abstract/MED/20053150"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"DNA inhibitor","chemblIds":["CHEMBL1475"],"references":[{"source":"PubMed","ids":["17373769"],"urls":["http://europepmc.org/abstract/MED/17373769"]}]}
{"actionType":"MODULATOR","mechanismOfAction":"Glucocorticoid receptor modulator","chemblIds":["CHEMBL3137316"],"targetName":"Glucocorticoid receptor","targetType":"single protein","targets":["ENSG00000113580"],"references":[{"source":"Other","ids":["http://ard.bmj.com/content/74/Suppl_2/737.3","http://www.abstracts2view.com/eular/view.php?nu=EULAR10L_THU0216"],"urls":["http://ard.bmj.com/content/74/Suppl_2/737.3","http://www.abstracts2view.com/eular/view.php?nu=EULAR10L_THU0216"]}]}
{"actionType":"PARTIAL AGONIST","mechanismOfAction":"C-X-C chemokine receptor type 4 partial agonist","chemblIds":["CHEMBL18442"],"targetName":"C-X-C chemokine receptor type 4","targetType":"single protein","targets":["ENSG00000121966"],"references":[{"source":"DailyMed","ids":["setid=a56b1b78-0ae2-41b4-9c76-98ad9d439199#section-12"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a56b1b78-0ae2-41b4-9c76-98ad9d439199#section-12"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase B-raf inhibitor","chemblIds":["CHEMBL2029988"],"targetName":"Serine/threonine-protein kinase B-raf","targetType":"single protein","targets":["ENSG00000157764"],"references":[{"source":"Other","ids":["http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf","http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf","http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf"],"urls":["http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf","http://ignyta.com/wp-content/uploads/2015/11/RXDX-105-ENA-Clinical-Poster.pdf","http://ignyta.com/wp-content/uploads/2015/11/ENA-2015-poster-RXDX-105.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Cannabinoid CB1 receptor antagonist","chemblIds":["CHEMBL3545289"],"targetName":"Cannabinoid CB1 receptor","targetType":"single protein","targets":["ENSG00000118432"],"references":[{"source":"Other","ids":["http://adisinsight.springer.com/drugs/800025707"],"urls":["http://adisinsight.springer.com/drugs/800025707"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Cannabinoid CB1 receptor antagonist","chemblIds":["CHEMBL562668"],"targetName":"Cannabinoid CB1 receptor","targetType":"single protein","targets":["ENSG00000118432"],"references":[{"source":"PubMed","ids":["19102698"],"urls":["http://europepmc.org/abstract/MED/19102698"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Purinergic receptor P2Y12 antagonist","chemblIds":["CHEMBL2103828"],"targetName":"Purinergic receptor P2Y12","targetType":"single protein","targets":["ENSG00000169313"],"references":[{"source":"PubMed","ids":["20608816"],"urls":["http://europepmc.org/abstract/MED/20608816"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Muscarinic acetylcholine receptor M2 antagonist","chemblIds":["CHEMBL1722209","CHEMBL1382"],"targetName":"Muscarinic acetylcholine receptor M2","targetType":"single protein","targets":["ENSG00000181072"],"references":[{"source":"PubMed","ids":["16465186","16465186"],"urls":["http://europepmc.org/abstract/MED/16465186","http://europepmc.org/abstract/MED/16465186"]},{"source":"DailyMed","ids":["setid=5e29f133-270c-4e5a-8493-e038c163a891","setid=5e29f133-270c-4e5a-8493-e038c163a891"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e29f133-270c-4e5a-8493-e038c163a891","http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e29f133-270c-4e5a-8493-e038c163a891"]},{"source":"Wikipedia","ids":["Tolterodine#Pharmacology","Tolterodine#Pharmacology"],"urls":["http://en.wikipedia.org/wiki/Tolterodine#Pharmacology","http://en.wikipedia.org/wiki/Tolterodine#Pharmacology"]}]}
{"actionType":"SEQUESTERING AGENT","mechanismOfAction":"Cyanide sequestering agent","chemblIds":["CHEMBL3833337"],"references":[{"source":"PubMed","ids":["27352227"],"urls":["http://europepmc.org/abstract/MED/27352227"]},{"source":"BNF","ids":["https://bnf.nice.org.uk/drug/dicobalt-edetate.html"],"urls":["https://bnf.nice.org.uk/drug/dicobalt-edetate.html"]}]}
{"mechanismOfAction":"Diagnostic agent","chemblIds":["CHEMBL1200457"],"references":[{"source":"FDA","ids":["label/2013/020937s022lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020937s022lbl.pdf"]}]}
{"mechanismOfAction":"Diagnostic agent","chemblIds":["CHEMBL1200593"],"references":[{"source":"DailyMed","ids":["setid=778aee03-7d4c-481a-be8a-a75db0702f5a"],"urls":["https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?audience=consumer&setid=778aee03-7d4c-481a-be8a-a75db0702f5a"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Epidermal growth factor receptor erbB1 inhibitor","chemblIds":["CHEMBL2103842"],"targetName":"Epidermal growth factor receptor erbB1","targetType":"single protein","targets":["ENSG00000146648"],"references":[{"source":"Other","ids":["http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf","http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/","http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf","http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/"],"urls":["http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf","http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/","http://arraybiopharma.com/files/8813/9810/8032/PubAttachment460.pdf","http://www.arraybiopharma.com/product-pipeline/other-compounds/aslan001-arry-543/"]}]}
{"actionType":"AGONIST","mechanismOfAction":"LXR-beta agonist","chemblIds":["CHEMBL3545238"],"targetName":"LXR-beta","targetType":"single protein","targets":["ENSG00000131408"],"references":[{"source":"PubMed","ids":["24833295","24833295"],"urls":["http://europepmc.org/abstract/MED/24833295","http://europepmc.org/abstract/MED/24833295"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Histamine H1 receptor antagonist","chemblIds":["CHEMBL1200618","CHEMBL914"],"targetName":"Histamine H1 receptor","targetType":"single protein","targets":["ENSG00000196639"],"references":[{"source":"DailyMed","ids":["setid=ac0c0247-3b20-445a-84c0-cb7f3939c823"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ac0c0247-3b20-445a-84c0-cb7f3939c823"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"TGF-beta receptor type I inhibitor","chemblIds":["CHEMBL2364611"],"targetName":"TGF-beta receptor type I","targetType":"single protein","targets":["ENSG00000106799"],"references":[{"source":"PubMed","ids":["25529192","25573078"],"urls":["http://europepmc.org/abstract/MED/25529192","http://europepmc.org/abstract/MED/25573078"]},{"source":"Other","ids":["http://www.lillyoncologypipeline.com/tgfbr1-kinase-inhibitor.aspx"],"urls":["http://www.lillyoncologypipeline.com/tgfbr1-kinase-inhibitor.aspx"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Serine/threonine-protein kinase AKT inhibitor","chemblIds":["CHEMBL462018"],"targetName":"Serine/threonine-protein kinase AKT","targetType":"protein family","targets":["ENSG00000105221","ENSG00000117020","ENSG00000142208"],"references":[{"source":"PubMed","ids":["15231645","19422047"],"urls":["http://europepmc.org/abstract/MED/15231645","http://europepmc.org/abstract/MED/19422047"]}]}
{"actionType":"ACTIVATOR","mechanismOfAction":"Antithrombin-III activator","chemblIds":["CHEMBL1201534"],"targetName":"Antithrombin-III","targetType":"single protein","targets":["ENSG00000117601"],"references":[{"source":"FDA","ids":["nda/2001/20-430S003_Orgaran_prntlbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/nda/2001/20-430S003_Orgaran_prntlbl.pdf"]},{"source":"ISBN","ids":["9780702034718 PP. 299"],"urls":["http://www.isbnsearch.org/isbn/9780702034718"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Poly [ADP-ribose] polymerase-1 inhibitor","chemblIds":["CHEMBL4112930"],"targetName":"Poly [ADP-ribose] polymerase-1","targetType":"single protein","targets":["ENSG00000143799"],"references":[{"source":"PubMed","ids":["32652442","33264017","32652442","33264017"],"urls":["http://europepmc.org/abstract/MED/32652442","http://europepmc.org/abstract/MED/33264017","http://europepmc.org/abstract/MED/32652442","http://europepmc.org/abstract/MED/33264017"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase receptor FLT3 inhibitor","chemblIds":["CHEMBL1944698"],"targetName":"Tyrosine-protein kinase receptor FLT3","targetType":"single protein","targets":["ENSG00000122025"],"references":[{"source":"PubMed","ids":["21860433","21860433","21860433","21860433","21860433","21860433"],"urls":["http://europepmc.org/abstract/MED/21860433","http://europepmc.org/abstract/MED/21860433","http://europepmc.org/abstract/MED/21860433","http://europepmc.org/abstract/MED/21860433","http://europepmc.org/abstract/MED/21860433","http://europepmc.org/abstract/MED/21860433"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"ALK tyrosine kinase receptor inhibitor","chemblIds":["CHEMBL3545051"],"targetName":"ALK tyrosine kinase receptor","targetType":"single protein","targets":["ENSG00000171094"],"references":[{"source":"PubMed","ids":["25322323","25888090","25322323","25888090"],"urls":["http://europepmc.org/abstract/MED/25322323","http://europepmc.org/abstract/MED/25888090","http://europepmc.org/abstract/MED/25322323","http://europepmc.org/abstract/MED/25888090"]},{"source":"DOI","ids":["10.1158/1538-7445.AM2015-3232","10.1158/1538-7445.AM2015-3232"],"urls":["http://cancerres.aacrjournals.org/content/75/15_Supplement/3232","http://cancerres.aacrjournals.org/content/75/15_Supplement/3232"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Tyrosine-protein kinase receptor UFO inhibitor","chemblIds":["CHEMBL3984441"],"targetName":"Tyrosine-protein kinase receptor UFO","targetType":"single protein","targets":["ENSG00000167601"],"references":[{"source":"Other","ids":["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755"],"urls":["https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755","https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.9583","https://cancerres.aacrjournals.org/content/74/19_Supplement/1755"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Monoamine oxidase B inhibitor","chemblIds":["CHEMBL48582","CHEMBL396778"],"targetName":"Monoamine oxidase B","targetType":"single protein","targets":["ENSG00000069535"],"references":[{"source":"FDA","ids":["label/2017/207145lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207145lbl.pdf"]},{"source":"Other","ids":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002396/WC500184965.pdf"],"urls":["http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/002396/WC500184965.pdf"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Endothelin receptor, ET-A/ET-B antagonist","chemblIds":["CHEMBL2105740","CHEMBL282724"],"targetName":"Endothelin receptor, ET-A/ET-B","targetType":"protein family","targets":["ENSG00000136160","ENSG00000151617"],"references":[{"source":"PubMed","ids":["17385944","21451953","22683289"],"urls":["http://europepmc.org/abstract/MED/17385944","http://europepmc.org/abstract/MED/21451953","http://europepmc.org/abstract/MED/22683289"]}]}
{"actionType":"ANTAGONIST","mechanismOfAction":"Adrenergic receptor alpha-2 antagonist","chemblIds":["CHEMBL2107339","CHEMBL1366933"],"targetName":"Adrenergic receptor alpha-2","targetType":"protein family","targets":["ENSG00000150594","ENSG00000184160","ENSG00000274286"],"references":[{"source":"PubMed","ids":["21246188","26047892","21246188","26047892","21246188","26047892","21246188","26047892"],"urls":["http://europepmc.org/abstract/MED/21246188","http://europepmc.org/abstract/MED/26047892","http://europepmc.org/abstract/MED/21246188","http://europepmc.org/abstract/MED/26047892","http://europepmc.org/abstract/MED/21246188","http://europepmc.org/abstract/MED/26047892","http://europepmc.org/abstract/MED/21246188","http://europepmc.org/abstract/MED/26047892"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Macrophage colony stimulating factor receptor inhibitor","chemblIds":["CHEMBL2109323"],"targetName":"Macrophage colony stimulating factor receptor","targetType":"single protein","targets":["ENSG00000182578"],"references":[{"source":"Other","ids":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=700191"],"urls":["https://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=700191"]},{"source":"PubMed","ids":["26098772"],"urls":["http://europepmc.org/abstract/MED/26098772"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"2'-deoxyadenosine hydrolytic enzyme","chemblIds":["CHEMBL3990026"],"references":[{"source":"FDA","ids":["label/2018/761092s000lbl.pdf","label/2018/761092s000lbl.pdf"],"urls":["https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761092s000lbl.pdf","https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/761092s000lbl.pdf"]}]}
{"actionType":"HYDROLYTIC ENZYME","mechanismOfAction":"Triglyceride hydrolytic enzyme","chemblIds":["CHEMBL2108703"],"references":[{"source":"PubMed","ids":["21831726","21831726","21831726"],"urls":["http://europepmc.org/abstract/MED/21831726","http://europepmc.org/abstract/MED/21831726","http://europepmc.org/abstract/MED/21831726"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Interleukin-31 receptor subunit alpha inhibitor","chemblIds":["CHEMBL4297794"],"targetName":"Interleukin-31 receptor subunit alpha","targetType":"single protein","targets":["ENSG00000164509"],"references":[{"source":"PubMed","ids":["28538126","32640132"],"urls":["http://europepmc.org/abstract/MED/28538126","http://europepmc.org/abstract/MED/32640132"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL2107525","CHEMBL1060"],"references":[{"source":"PubMed","ids":["428168"],"urls":["http://europepmc.org/abstract/MED/428168"]}]}
{"mechanismOfAction":"Unknown","chemblIds":["CHEMBL6466"],"references":[{"source":"PubMed","ids":["20024932","24561300","25553437"],"urls":["http://europepmc.org/abstract/MED/20024932","http://europepmc.org/abstract/MED/24561300","http://europepmc.org/abstract/MED/25553437"]},{"source":"Other","ids":["http://www.sciencedirect.com/topics/neuroscience/coumarins"],"urls":["http://www.sciencedirect.com/topics/neuroscience/coumarins"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Farnesyl diphosphate synthase inhibitor","chemblIds":["CHEMBL1654","CHEMBL923"],"targetName":"Farnesyl diphosphate synthase","targetType":"single protein","targets":["ENSG00000160752"],"references":[{"source":"DailyMed","ids":["setid=4423d70a-b120-4653-bcf3-0c5ea8b97b0e"],"urls":["http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=4423d70a-b120-4653-bcf3-0c5ea8b97b0e"]},{"source":"PubMed","ids":["11160603","15028820","16006204","16835450"],"urls":["http://europepmc.org/abstract/MED/11160603","http://europepmc.org/abstract/MED/15028820","http://europepmc.org/abstract/MED/16006204","http://europepmc.org/abstract/MED/16835450"]}]}
{"actionType":"SUBSTRATE","mechanismOfAction":"Norepinephrine transporter substrate","chemblIds":["CHEMBL1615779","CHEMBL818"],"targetName":"Norepinephrine transporter","targetType":"single protein","targets":["ENSG00000103546"],"references":[{"source":"FDA","ids":["label/2018/209607s000lbl.pdf"],"urls":["http://www.accessdata.fda.gov/drugsatfda_docs/label/2018/209607s000lbl.pdf"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Vascular endothelial growth factor B inhibitor","chemblIds":["CHEMBL2108313"],"targetName":"Vascular endothelial growth factor B","targetType":"single protein","targets":["ENSG00000173511"],"references":[{"source":"PubMed","ids":["25960634","18246030","23950958","25960634","18246030","22958404","23950958","25960634","22958404","23950958","25960634"],"urls":["http://europepmc.org/abstract/MED/25960634","http://europepmc.org/abstract/MED/18246030","http://europepmc.org/abstract/MED/23950958","http://europepmc.org/abstract/MED/25960634","http://europepmc.org/abstract/MED/18246030","http://europepmc.org/abstract/MED/22958404","http://europepmc.org/abstract/MED/23950958","http://europepmc.org/abstract/MED/25960634","http://europepmc.org/abstract/MED/22958404","http://europepmc.org/abstract/MED/23950958","http://europepmc.org/abstract/MED/25960634"]}]}
{"actionType":"AGONIST","mechanismOfAction":"Vitamin D receptor agonist","chemblIds":["CHEMBL1536"],"targetName":"Vitamin D receptor","targetType":"single protein","targets":["ENSG00000111424"],"references":[{"source":"PubMed","ids":["16949927","17218095","17519354"],"urls":["http://europepmc.org/abstract/MED/16949927","http://europepmc.org/abstract/MED/17218095","http://europepmc.org/abstract/MED/17519354"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Protective antigen inhibitor","chemblIds":["CHEMBL2109303"],"targetName":"Protective antigen","targetType":"single protein","targets":[],"references":[{"source":"PubMed","ids":["16428748","24733473"],"urls":["http://europepmc.org/abstract/MED/16428748","http://europepmc.org/abstract/MED/24733473"]}]}
{"actionType":"INHIBITOR","mechanismOfAction":"Thiazide-sensitive sodium-chloride cotransporter inhibitor","chemblIds":["CHEMBL1763"],"targetName":"Thiazide-sensitive sodium-chloride cotransporter","targetType":"single protein","targets":["ENSG00000070915"],"references":[{"source":"DOI","ids":["10.1056/NEJMra0907219"],"urls":["http://www.nejm.org/doi/full/10.1056/NEJMra0907219"]}]}
